공황장애 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 5.7%의 성장률(CAGR)을 기록하며 139억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 새로운 약리학적 치료, 원격 정신의료 서비스, 동반질환에 대한 관심, 세계 정신건강 이니셔티브, 치료의 약리유전체학, 공공 교육 프로그램 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 디지털 정신건강 중재, 공황장애 치료를 위한 원격 의료, 약수처리의 혁신, 신경생물학적 연구, 원격 모니터링, 웨어러블 기술 등이 있습니다.
정신과 환자의 급증은 가까운 미래에 공황장애 시장의 성장을 견인할 것으로 보입니다. 인지적, 정서적, 사회적 기능의 다양한 측면을 방해하는 정신 건강 상태를 앓고 있는 정신과 환자들은 갑작스러운 극심한 불안 에피소드를 특징으로 하는 공황장애에 걸리기 쉽습니다. 정신질환의 치료는 공황발작의 증상을 완화하고, 전반적인 행복감을 증진하며, 효과적인 대처 능력을 키우기 위해 치료, 약수처리, 생활습관 개선을 결합한 다각적인 접근법을 사용하는 경우가 많습니다. 예를 들어, Mental Health America의 'State of Mental Health in America 2022' 보고서에 따르면, 2021년에는 미국 전체 인구의 19.00%인 47,132,000명인 반면, 2022년에는 19.86%인 49,564,000명으로 증가할 것으로 전망하고 있습니다. 차지하는 49,564,000명으로 정신과 환자 증가가 지적되고 있습니다. 따라서 정신과 환자 수 증가가 공황장애 시장의 성장을 견인할 것으로 보입니다.
텔레헬스의 이용 확대가 공황장애 시장을 크게 견인할 것으로 예상됩니다. 화상회의, 전화, 보안 메시징과 같은 전자 통신 수단을 포함한 텔레헬스는 공황장애를 앓고 있는 사람들을 위한 심리치료와 상담을 포함한 원격 진료 및 헬스케어 서비스를 가능하게 합니다. 이 기술을 통해 환자는 직접 방문하지 않고도 정신건강 서비스를 쉽게 받을 수 있어 접근성과 편의성을 높일 수 있습니다. 예를 들어, 2023년 4월 FAIR Health Inc.가 발표한 보고서에 따르면, 원격의료 이용이 7.3% 증가하여 2022년 12월의 5.5%에서 2023년 1월에는 의료 청구액의 5.9%로 상승할 것으로 예상됩니다. 원격 의료가 계속 성장함에 따라 공황장애 시장에 미치는 영향은 효과적인 치료 옵션과 원격 치료 서비스에 대한 수요를 촉진할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 공황장애 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업 분석
- 세계의 공황장애 시장 : 성장률 분석
- 세계의 공황장애 시장 실적 : 규모와 성장, 2019-2024
- 세계의 공황장애 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 공황장애 전체 시장(TAM)
제6장 시장 세분화
- 세계의 공황장애 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 광장 공포증
- 사회불안 장애(SAD)
- 강박성 장애(OCD)
- 조울증
- 외상 후 스트레스 장애(PTSD)
- 주요 우울 장애
- 세계의 공황장애 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 약제
- 베타 차단제
- 세로토닌 및 노르에피네프린 재흡수 억제제(SNRI)
- 벤조디아제핀
- 항간질
- 기타 치료법
- 세계의 공황장애 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 비경구
- 기타 투여 경로
- 세계의 공황장애 시장 : 최종 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 공황장애 시장 : 광장 공포증 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 상황적 광장 공포증
- 비상황적 광장 공포증
- 세계의 공황장애 시장 : 사회불안 장애(SAD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 수행 불안
- 일반화된 사회불안
- 세계의 공황장애 시장 : 강박성 장애(OCD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 오염 강박성 장애
- 해악 강박성 장애
- OCD 체크
- 대칭성 강박성 장애
- 세계의 공황장애 시장 : 조울증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 조울증 I형
- 조울증 II형
- 기분 순환성 장애
- 세계의 공황장애 시장 : 외상 후 스트레스 장애(PTSD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 급성 PTSD
- 만성 PTSD
- 복잡성 PTSD
- 세계의 공황장애 시장 : 주요 우울 장애별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 재발성 주요 우울 장애
- 단발성 주요 우울 장애
제7장 지역별/국가별 분석
- 세계의 공황장애 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 공황장애 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 공황장애 시장 : 경쟁 구도
- 공황장애 시장 : 기업 개요
- F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- GlaxoSmithKline plc
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH.
- Baxter Inc
- Teva Pharmaceutical Industries Ltd
- Mylan N.V.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Bausch Health Companies Inc.
- H. Lundbeck A/S
- Shionogi & Co Ltd.
- Recordati S.p.A
- Neurocrine Biosciences Inc
- Neuraxpharm
- Actavis Plc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 공황장애 시장(2029년) : 새로운 기회를 제공하는 국가
- 공황장애 시장(2029년) : 새로운 기회를 제공하는 부문
- 공황장애 시장(2029년) : 성장 전략
제36장 부록
LSH
Panic disorder is a specific type of anxiety condition characterized by unexpected and recurring episodes of intense anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Treatment for panic disorder typically involves a combination of medication and psychotherapy.
The main subtypes of panic disorders include agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCS), bipolar disorder, post-traumatic stress disorder (PTSD), and major depressive disorder. Agoraphobia involves the intentional avoidance of places or situations that may trigger panic symptoms, leading to feelings of confinement, helplessness, or social discomfort. Various treatment options include medication, beta-blockers, serotonin and norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, anti-epilepsy medications, and others, which can be administered orally, through injections, and other methods. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacy stores.
The panic disorders market research report is one of a series of new reports from The Business Research Company that provides panic disorders market statistics, including panic disorders industry global market size, regional shares, competitors with a panic disorders market share, detailed panic disorders market segments, market trends and opportunities, and any further data you may need to thrive in the panic disorders industry. This panic disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The panic disorders market size has grown steadily in recent years. It will grow from $10.73 billion in 2024 to $11.19 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to antidepressant medications, increased mental health awareness, increased stress levels, access to mental health services, advancements in diagnostic criteria.
The panic disorders market size is expected to see strong growth in the next few years. It will grow to $13.96 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to emerging pharmacological treatments, telepsychiatry services, focus on comorbidities, global mental health initiatives, pharmacogenomics in treatment, public education programs. Major trends in the forecast period include digital mental health interventions, telemedicine for panic disorder treatment, innovations in medications, neurobiological research, remote monitoring and wearable technology.
An upsurge in the population of psychiatric patients is poised to propel the expansion of the panic disorder market in the foreseeable future. Psychiatric patients, affected by mental health conditions that disrupt various aspects of their cognitive, emotional, and social functioning, are susceptible to panic disorder, characterized by sudden and intense episodes of anxiety. Treatment for individuals dealing with psychiatric conditions often involves a multifaceted approach combining therapy, medication, and lifestyle modifications to alleviate panic attack symptoms, enhance overall well-being, and foster effective coping mechanisms. For instance, the State of Mental Health in America 2022 report by Mental Health America noted an increase in psychiatric patients, reaching 49,564,000 individuals, constituting 19.86% of the total US population in 2022, compared to 47,132,000 individuals, comprising 19.00% of the total US population in 2021. Hence, the rise in psychiatric patient numbers is set to drive the growth of the panic disorder market.
The growing use of telehealth is expected to significantly boost the panic disorders market. Telehealth, which involves electronic communication methods like videoconferencing, phone calls, and secure messaging, enables remote consultations and healthcare services, including psychotherapy and counseling for individuals suffering from panic disorders. This technology makes it easier for patients to access mental health services without the need for in-person visits, improving accessibility and convenience. For example, a report from FAIR Health Inc. in April 2023 revealed a 7.3% increase in telehealth usage, rising from 5.5% in December 2022 to 5.9% of medical claim lines in January 2023. As telehealth continues to grow, its impact on the panic disorders market is expected to drive demand for effective treatment options and remote therapeutic services.
Key companies engaged in the panic disorder market are concentrating on the development of advanced medications, notably extended-release capsules, to fortify their foothold in the market. Extended-release capsules are medications designed to gradually release the active ingredients over an extended period, typically 12 or 24 hours, suitable for managing conditions requiring prolonged medication. As an example, in May 2023, Granules India Ltd., an Indian pharmaceutical company, obtained abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. These capsules have demonstrated bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed to manage various conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They operate by increasing serotonin and norepinephrine levels in the brain, usually starting at a dosage of 75 mg per day and adjusted as required under a doctor's supervision.
In February 2023, Vistagen Therapeutics Inc., a clinical-stage biopharmaceutical company based in the United States, successfully acquired Pherin Pharmaceuticals Inc. for an undisclosed sum. This strategic acquisition positions Vistagen to advance and bring to market innovative treatments designed for individuals dealing with depression and anxiety disorders. The collaboration is anticipated to enhance the commercial prospects of each drug candidate, strengthening Vistagen's portfolio in addressing mental health challenges. Pherin Pharmaceuticals Inc., the acquired company, specializes in drug development focused on panic disorders.
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.
North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the panic disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The panic disorder market consists of revenue earned by entities by providing services such as physical tests, cognitive behavioral therapy (CBT), and psychological evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic disorder market includes sales of tablets and injectables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Panic Disorders Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on panic disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for panic disorders ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panic disorders market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder
- 2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments
- 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
- 4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores
- Subsegments:
- 1) By Agoraphobia: Situational Agoraphobia; Non-Situational Agoraphobia
- 2) By Social Anxiety Disorder (SAD): Performance Anxiety; Generalized Social Anxiety
- 3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD; Harm OCD; Checking OCD; Symmetry OCD
- 4) By Bipolar Disorder: Bipolar I Disorder; Bipolar II Disorder; Cyclothymic Disorder
- 5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD; Chronic PTSD; Complex PTSD
- 6) By Major Depressive Disorder: Recurrent Major Depressive Disorder; Single Episode Major Depressive Disorder
- Companies Mentioned: F. Hoffmann-La Roche Ltd; Sanofi S.A; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Panic Disorders Market Characteristics
3. Panic Disorders Market Trends And Strategies
4. Panic Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Panic Disorders Growth Analysis And Strategic Analysis Framework
- 5.1. Global Panic Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Panic Disorders Market Growth Rate Analysis
- 5.4. Global Panic Disorders Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Panic Disorders Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Panic Disorders Total Addressable Market (TAM)
6. Panic Disorders Market Segmentation
- 6.1. Global Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Agoraphobia
- Social Anxiety Disorder (SAD)
- Obsessive-Compulsive Disorder (OCD)
- Bipolar Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Major Depressive Disorder
- 6.2. Global Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medication
- Beta Blockers
- Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
- Benzodiazepines
- Anti-Epilepsy
- Other Treatments
- 6.3. Global Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Routes Of Administrations
- 6.4. Global Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retailer Pharmacies
- Online Pharmacy Stores
- 6.5. Global Panic Disorders Market, Sub-Segmentation Of Agoraphobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Situational Agoraphobia
- Non-Situational Agoraphobia
- 6.6. Global Panic Disorders Market, Sub-Segmentation Of Social Anxiety Disorder (SAD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Performance Anxiety
- Generalized Social Anxiety
- 6.7. Global Panic Disorders Market, Sub-Segmentation Of Obsessive-Compulsive Disorder (OCD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Contamination OCD
- Harm OCD
- Checking OCD
- Symmetry OCD
- 6.8. Global Panic Disorders Market, Sub-Segmentation Of Bipolar Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bipolar I Disorder
- Bipolar II Disorder
- Cyclothymic Disorder
- 6.9. Global Panic Disorders Market, Sub-Segmentation Of Post-Traumatic Stress Disorder (PTSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute PTSD
- Chronic PTSD
- Complex PTSD
- 6.10. Global Panic Disorders Market, Sub-Segmentation Of Major Depressive Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Recurrent Major Depressive Disorder
- Single Episode Major Depressive Disorder
7. Panic Disorders Market Regional And Country Analysis
- 7.1. Global Panic Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Panic Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Panic Disorders Market
- 8.1. Asia-Pacific Panic Disorders Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Panic Disorders Market
- 9.1. China Panic Disorders Market Overview
- 9.2. China Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Panic Disorders Market
- 10.1. India Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Panic Disorders Market
- 11.1. Japan Panic Disorders Market Overview
- 11.2. Japan Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Panic Disorders Market
- 12.1. Australia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Panic Disorders Market
- 13.1. Indonesia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Panic Disorders Market
- 14.1. South Korea Panic Disorders Market Overview
- 14.2. South Korea Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Panic Disorders Market
- 15.1. Western Europe Panic Disorders Market Overview
- 15.2. Western Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Panic Disorders Market
- 16.1. UK Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Panic Disorders Market
- 17.1. Germany Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Panic Disorders Market
- 18.1. France Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Panic Disorders Market
- 19.1. Italy Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Panic Disorders Market
- 20.1. Spain Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Panic Disorders Market
- 21.1. Eastern Europe Panic Disorders Market Overview
- 21.2. Eastern Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Panic Disorders Market
- 22.1. Russia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Panic Disorders Market
- 23.1. North America Panic Disorders Market Overview
- 23.2. North America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Panic Disorders Market
- 24.1. USA Panic Disorders Market Overview
- 24.2. USA Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Panic Disorders Market
- 25.1. Canada Panic Disorders Market Overview
- 25.2. Canada Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Panic Disorders Market
- 26.1. South America Panic Disorders Market Overview
- 26.2. South America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Panic Disorders Market
- 27.1. Brazil Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Panic Disorders Market
- 28.1. Middle East Panic Disorders Market Overview
- 28.2. Middle East Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Panic Disorders Market
- 29.1. Africa Panic Disorders Market Overview
- 29.2. Africa Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Panic Disorders Market Competitive Landscape And Company Profiles
- 30.1. Panic Disorders Market Competitive Landscape
- 30.2. Panic Disorders Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Panic Disorders Market Other Major And Innovative Companies
- 31.1. GlaxoSmithKline plc
- 31.2. Eli Lilly and Company
- 31.3. Boehringer Ingelheim International GmbH.
- 31.4. Baxter Inc
- 31.5. Teva Pharmaceutical Industries Ltd
- 31.6. Mylan N.V.
- 31.7. Pfizer Inc.
- 31.8. Sun Pharmaceutical Industries Ltd
- 31.9. Bausch Health Companies Inc.
- 31.10. H. Lundbeck A/S
- 31.11. Shionogi & Co Ltd.
- 31.12. Recordati S.p.A
- 31.13. Neurocrine Biosciences Inc
- 31.14. Neuraxpharm
- 31.15. Actavis Plc.
32. Global Panic Disorders Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Panic Disorders Market
34. Recent Developments In The Panic Disorders Market
35. Panic Disorders Market High Potential Countries, Segments and Strategies
- 35.1 Panic Disorders Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Panic Disorders Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Panic Disorders Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
